SCHEMBL23630682

SCHEMBL23630682

CC(C)(C)OC(=O)c1cc(OC(=O)c2cc(OC(=O)c3cc(O)c4c(c3)OC(c3ccccc3)(c3ccccc3)O4)c3c(c2)OC(c2ccccc2)(c2ccccc2)O3)c2c(c1)OC(c1ccccc1)(c1ccccc1)O2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.38
POLB P06746 3/20 0.34
POLA1 P09884 1/20 0.34
ANTXR2 P58335 1/20 0.34
NSD2 O96028 1/20 0.34
CNR1 P21554 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 3/20 0.33
KMT2A Q03164 3/20 0.33
ESR1 P03372 3/20 0.33
ESR2 Q92731 3/20 0.33
MEN1 O00255 2/20 0.33
TSHR P16473 1/20 0.33
JAK2 O60674 1/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23630688 1.00 SERPINE1 (0.38) SERPINE1POLBPOLA1ANTXR2NSD2
SCHEMBL21584398 0.92 CNR1 (0.39) SERPINE1NSD2CNR1TSHRHSD17B10
SCHEMBL24621905 0.90 HIF1A (0.35) SERPINE1CNR1SIRT2SIRT1SLC7A5
SCHEMBL26710713 0.88 CNR1 (0.32) CNR1
SCHEMBL23630689 0.88 POLB (0.47) SERPINE1POLBPOLA1ANTXR2NSD2
SCHEMBL23957510 0.88 POLB (0.47) SERPINE1POLBPOLA1ANTXR2NSD2
SCHEMBL23630719 0.88 POLB (0.47) SERPINE1POLBPOLA1ANTXR2NSD2
SCHEMBL30307918 0.88 CNR1 (0.39) CNR1SMN1; SMN2TSHRSIRT2SIRT1
SCHEMBL28551345 0.88 CNR1 (0.39) CNR1SMN1; SMN2TSHRSIRT2SIRT1
SCHEMBL23630726 0.87 NSD2 (0.43) SERPINE1POLBPOLA1ANTXR2NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12521410-B2 Compounds and pharmaceutical uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2026-01-13 US disclosed
CN-112566894-B Potent inhibitors of D-amino acid oxidase (DAAO) and uses thereof 心悦生医股份有限公司 2025-01-17 CN disclosed
US-20240180945-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2024-06-06 US disclosed
US-11793823-B2 Compounds and pharmaceutical uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2023-10-24 US disclosed
US-11793823-B2 Compounds and pharmaceutical uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2023-10-24 US disclosed
US-11793823-B2 Compounds and pharmaceutical uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2023-10-24 US disclosed
CN-115836062-A Compound and medical application thereof 心悦生医股份有限公司 2023-03-21 CN disclosed
EP-4139275-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF Syneurx International (Taiwan) Corp. (TW) 2023-03-01 EP disclosed
US-20220218730-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2022-07-14 US disclosed
US-20220218730-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2022-07-14 US disclosed
WO-2021213500-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (CN) 2021-10-28 WO disclosed
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2021-07-15 US disclosed
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF DAO, DDO, DDC SERPINE1 1124/4885POLB 1656/4885POLA1 1865/4885
US-20220218730-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF HRH4, OR10J3, CYP3A5 SERPINE1 2936/4885POLB 4471/4885POLA1 4203/4885
US-11793823-B2 Compounds and pharmaceutical uses thereof HRH4, OR10J3, CYP3A5 SERPINE1 2936/4885POLB 4471/4885POLA1 4203/4885
US-20240180945-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF HRH4, OR10J3, CYP3A5 SERPINE1 2936/4885POLB 4471/4885POLA1 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.